Surrozen, Inc. Common (SRZN) is a publicly traded Healthcare sector company. As of September 8, 2026, SRZN trades at $22.72 with a market cap of $267.51M and a P/E ratio of -0.58. SRZN moved +0.97% today. Year to date, SRZN is +0.71%; over the trailing twelve months it is +86.56%. Its 52-week range spans $5.90 to $35.00. Analyst consensus is strong buy with an average price target of $44.60. Rallies surfaces SRZN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for SRZN, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $22.72 |
| Market Cap | $267.51M |
| P/E Ratio | -0.58 |
| EPS | $-39.08 |
| Dividend Yield | 0.00% |
| 52-Week High | $35.00 |
| 52-Week Low | $5.90 |
| Volume | 37.72K |
| Avg Volume | 0 |
| Revenue (TTM) | $11.51M |
| Net Income | $-332.13M |
| Gross Margin | 0.00% |
5 analysts cover SRZN: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $44.60.